This article may have been created or edited in return for undisclosed payments, a violation of Wikipedia's terms of use. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. (March 2024) |
Matthew Schissler | |
---|---|
Alma mater | St. Mary's College of Maryland, 1993 |
Occupation(s) | Founder and Member, GHS Investments, LLC and Work Your Core Investments, LLC. Board Member of Aztec Airways, Inc. |
Years active | 2001-Present |
Known for | Founder, Cord Blood America, Inc. (CBAI) |
Matthew Schissler (born June 9, 1971) is an American business executive who has served in leadership roles in a number of privately and publicly held companies. He's most notable for having founded and managed Cord Blood America, Inc. (CBAI), a company specializing in the harvesting and storage of umbilical stem cells in the U.S. and worldwide. He currently manages a series of private investment fund, focused a wide variety of companies exhibiting significant growth potential. Matthew Schissler is notably a Founder and Member of GHS Investments, LLC.
Schissler holds a degree in Biology and Public Policy from St. Mary’s College of Maryland in 1993. [1]
In 2003 Schissler founded Cord Blood America, Inc. (CBAI), a company specializing in harvesting and storing stem cells in the U.S. and abroad, serving as the company's chairman of the board and CEO until 2012. [1] Parents who subscribe to CBAI supply the company with a small amount of blood taken from the umbilical cord at the birth of a child, which the company stores in the event that the family may need it as the result of a medical condition that could benefit from a stem cell treatment. [2] At the time, he also served as CEO and Chairman of the board for Cord Partners Inc., CBAI's original stem storage company, which was absorbed by CBAI in 2005. [3] [4]
In 2006, CBAI purchased the assets of the Cryobank for Oncologic and Reproductive Donors (CORD), a bank in Middletown, New York, with an inventory of 750 donors. In 2007, the company acquired Philadelphia-based CorCell Inc., at the time the fourth-largest umbilical cord blood bank in America. [5] The same year, the company acquired CureSource, a Charleston-based cord blood storage facility that serviced about 340 customers. [6] CorCell maintained its presence and name as CorCell Inc., a subsidiary of the parent company CBAI, being responsible for cord blood storage facilities. [7] Schissler served as CorCell Inc.'s chairman, CEO and president. [3] In 2010, they acquired 51 percent of stellacure GmbH of Hamburg, at the time the third-largest cord blood banking service in Germany, as well as a majority ownership of BioCells Argentina. [8] [9]
In 2010, Schissler relocated the company to Las Vegas, citing multiple reasons, including his frequent travels to Las Vegas for trade conventions, business-friendly tax climates and the ability to have low-cost laboratory space near the airport. [10] [11] [12] Schissler also served as the founder and president of China Stem Cells, Inc., a stem cell storage facility in northeast China. [13] [14] In 2011, CBAI acquired two cord blood companies based in Chicago - Reproductive Genetics Institute, Inc, and NeoCells. [15] April 12, 2023 / CBA Florida, Inc. (www.cbafloridainc.com) ("CBAI" or the "Company") today announced that its Board of Directors (the "Board") has approved a liquidating cash distribution of approximately $2 million, or $0.00157 per share, to shareholders of record as of April 4, 2023. With CBAI liquidating, presently the leading cord blood banks in the U.S. include Americord, Cord Blood Registry, and Viacord. [16]
Schissler is a Founder and Managing Member of GHS Investments, LLC. Founded in 2015, GHS Investments, LLC is a privately held "super value" fund focused on small to mid-cap companies, with an investment focus on companies exhibiting significant growth potential. [17] [18] [19] [20] [21]
Schissler is a Founder and Managing Member of Work Your Core Investments (WYC), LLC. Founded in 2021, WYC is a privately held fund focused on purchasing or investing in franchises and other fitness related concepts, with an investment focus on unique performance concepts exhibiting significant growth potential. [22]
In 2021, Schissler became a member of the Board of Directors for Aztec Airways of Fort Lauderdale Florida. Aztec Airways was formed in 1998, and is certificated by the United States Federal Aviation Administration under FAR part 135 as an On-Demand/Commuter Scheduled US Air Carrier. [23]
In 2011, Schissler was named chairman of the Biotech Committee for the Nevada Development Authority. [24] He has also served on the board of advisors for the Las Vegas Science Festival and the board of directors for the Las Vegas Natural History Museum, and is a member of the Karma Foundation. [25] [26]
In 2008, Schissler was a finalist for the Ernst and Young Entrepreneur of the Year Award. [3]
In placental mammals, the umbilical cord is a conduit between the developing embryo or fetus and the placenta. During prenatal development, the umbilical cord is physiologically and genetically part of the fetus and normally contains two arteries and one vein, buried within Wharton's jelly. The umbilical vein supplies the fetus with oxygenated, nutrient-rich blood from the placenta. Conversely, the fetal heart pumps low-oxygen, nutrient-depleted blood through the umbilical arteries back to the placenta.
A cord blood bank is a facility which stores umbilical cord blood for future use. Both private and public cord blood banks have developed in response to the potential for cord blood in treating diseases of the blood and immune systems. Public cord blood banks accept donations to be used for anyone in need, and as such function like public blood banks. Traditionally, public cord blood banking has been more widely accepted by the medical community. Private cord blood banks store cord blood solely for potential use by the donor or donor's family. Private banks typically charge around $2,000 for the collection and around $200 a year for storage.
Cord blood is blood that remains in the placenta and in the attached umbilical cord after childbirth. Cord blood is collected because it contains stem cells, which can be used to treat hematopoietic and genetic disorders such as cancer.
NV Energy is a public utility which generates, transmits and distributes electric service in northern and southern Nevada, including the Las Vegas Valley, and provides natural gas service in the Reno–Sparks metropolitan area of northern Nevada. Based in Las Vegas, Nevada, it serves about 1.3 million customers and over 40 million tourists annually.
The Singapore Cord Blood Bank is Singapore's only public cord blood bank that collects, processes and stores donated umbilical cord blood for use in stem cell transplants. Its cord blood units may be searched for use by qualifying transplant centers around the world.
The National Marrow Donor Program (NMDP) is a nonprofit organization founded in 1986 and based in Minneapolis, Minnesota, that operates the Be The Match Registry of volunteer hematopoietic cell donors and umbilical cord blood units in the United States.
Stephens Media LLC was a Las Vegas, Nevada, United States, diversified media investment company. It owned stakes in the California Newspapers Partnership and the Northwest Arkansas Democrat Gazette.
Crioestaminal - Saúde e Tecnologia, SA, was founded in 2003, becoming the first umbilical cord blood bank in the Iberian Peninsula. Since then, it has developed into the largest Portuguese and one of the five largest cryo-preservation banks in Europe with over 60,000 stored samples. Crioestaminal was the first company to be authorized by the Portuguese Ministry of Health and is the only family bank with an AABB accreditation in Portugal. In Europe, there are only five banks with an AABB accreditation.
Precision Cellular Storage is a transport quality cord blood stem cell bank, with operations in Doha and the United Kingdom. The company was formerly named Virgin Health Bank until 2018, when it closed to new business and focused on the storage of existing customers' units.
Vitalant is a nonprofit organization that collects blood from volunteer donors and provides blood, blood products and services across the United States. It was founded in 1943 as the Salt River Valley Blood Bank in Phoenix, Arizona.
Lorenzo Joseph Fertitta is an American billionaire businessman and philanthropist. He is chairman of Fertitta Capital, director of Red Rock Resorts Inc, and former CEO of the Ultimate Fighting Championship.
The cord blood bank Cryo-Save AG shut their doors at the end of June 2019. By 17 September, they filed for liquidation. The brand name CryoSave and the client database now belong to CSG-BIO. The clients’ umbilical cords were moved in the 2nd quarter of 2019, to the Polish cord blood bank PBKM, the head of the FamiCord network. FamiCord does not own the cords, they are operating under a third party storage contract.
Cord lining, cord tissue, or umbilical cord lining membrane, is the outermost layer of the umbilical cord. As the umbilical cord itself is an extension of the placenta, the umbilical cord lining membrane is an extension of the amniotic membrane covering the placenta. The umbilical cord lining membrane comprises two layers: the amniotic layer and the sub-amniotic layer. The umbilical cord lining membrane is a rich source of two strains of stem cells (CLSCs): epithelial stem cells (CLECs) and mesenchymal stem cells (CLMCs). Discovered by Singapore-based CellResearch Corporation in 2004, this is the best known source for harvesting human stem cells.
Incorporated in May 2001, Cordlife Group Limited, is a consumer health company and one of the leading providers of cord blood and cord lining banking services in Asia. Cordlife has been listed on the mainboard of SGX since March 2012.
Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.
Cynthia Fisher is an American businesswoman, entrepreneur, and corporate board director. She was a pioneer in the stem cell industry, founding the cord blood stem cell banking company, ViaCord, Inc., in 1993. In 2000, she co-founded ViaCell, which went public in 2005 and was subsequently acquired by PerkinElmer for its ViaCord brand.
Cells4Life is a private stem cell bank based in the United Kingdom. It procures, processes and stores human umbilical cord blood and tissue samples that may be used for stem cell treatments. Cells4Life is the largest provider of umbilical cord blood banking services in the UK, with over 50% of the UK market. Based in Burgess Hill, the company also provides umbilical stem cell storage and collection services in Spain, Italy, United Arab Emirates, Bulgaria, Pakistan and Kenya.
CellResearch Corporation is a biotechnology company with a primary focus on skin cell and cord lining stem cell research. CellResearch has one of the world's largest private skin-, scar-, and keloid-cell libraries which have been used for research by cell culture laboratories worldwide, including those at Harvard University, Procter & Gamble and Johnson & Johnson. It owns 39 patents worldwide with intellectual property for the isolation of stem cells from the umbilical cord lining membrane of all mammals, which also includes the banking and cultivation of these cells, as well as the therapeutic applications of these cells.
LifeCell International is an Indian biotechnology company established in 2004. It runs India's largest stem cell bank and has also diversified into diagnostics and tissue therapeutics. In 2017 the company launched a community stem cell banking which allows sharing of preserved umbilical cord stem cells among its members. The community stem cell banking is claimed to be among the largest and only one of its kind in India. It was reported in 2017 that LifeCell had preserved stem cells from 3,00,000 individuals in India and was expected to add 60,000 individuals every year in the future
BioBridge Global is a San Antonio-based nonprofit holding company that operates the South Texas Blood & Tissue Center, QualTex Laboratories, GenCure, and The Blood and Tissue Center Foundation. BioBridge Global supplies products and services in blood resource management, cellular therapy, donated umbilical cord blood and human tissue, and testing of blood, plasma, and tissue. The organization was initially established as the South Texas Regional Blood Bank in 1973.
{{cite web}}
: |author=
has generic name (help)